Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Prostaglandin endoperoxides. A new concept concerning the mode of action and release of prostaglandins

Journal Article · · Proc. Natl. Acad. Sci. U.S.A.; (United States)

Methods were developed for quantitative determination of the three major metabolites of arachidonic acid in human platelets, i.e., 12L-hydroxy-5,8,10,14-cicosatetraenoic acid (HETE), 12L-hydroxy-5,8,10-heptadecatrienoic acid (HHT) and 8-(1-hydroxy-3-oxopropyl)-9,12L-dihydroxy-5,10-heptadecadienoic acid (PHD). Aggregation of washed platelets by thrombin was accompanied by release of 1163 to 2175 ng/ml of HETE, 1129 to 2430 ng/ml of HHT, and 998 to 2299 ng/ml of PHD. The amount of PGG/sub 2/ (prostaglandin G/sub 2/) produced as calculated from the sum of the amounts of its metabolites (HHT and PHD) was 2477 to 5480 ng/ml. In contrast, the amounts of PGF/sub 2/ (prostaglandin E/sub 2/) and PGF/sub 2..cap alpha../ (prostaglandin F/sub 2..cap alpha../) released were approximately two orders of magnitude lower. In this system, the prostaglandins thus exert their biological action through the endoperoxides, which are almost exclusively metabolized to nonprostanoate structures and only to a small extent to the classical prostaglandins. Platelets from subjects given aspirin produced less than 5% of the above mentioned amounts of HHT and PHD, whereas the production of HETE was stimulated about 3-fold. This provides additional evidence for our earlier proposal that the anti-aggregating effect of aspirin is through inhibition of PGG/sub 2/ formation.

Research Organization:
Karolinska Inst., Stockholm
OSTI ID:
7086857
Journal Information:
Proc. Natl. Acad. Sci. U.S.A.; (United States), Journal Name: Proc. Natl. Acad. Sci. U.S.A.; (United States) Vol. 71:10; ISSN PNASA
Country of Publication:
United States
Language:
English